{
    "nct_id": "NCT06264700",
    "official_title": "Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness",
    "inclusion_criteria": "Inclusion:\n\nAdult caregivers will be eligible if they:\n\n* Are English speaking.\n* Have a child who is 1-10 years of age with SCD (any genotype) who has been prescribed hydroxyurea for at least 180 days prior to enrollment.\n* Note: Caregivers who have multiple children meeting criteria will only be able to enroll once.\n\nAdolescents (>11 years at enrollment) are eligible if they:\n\n* Are English speaking.\n* Are 11-25 years of age.\n* Have a diagnosis of SCD (any genotype) and have been prescribed hydroxyurea for at least 180 days prior to enrollment.\n\nExclusion:\n\n* Adolescents and caregivers of younger children who participated in the previous VDOT study will be excluded.\n* Adolescents and caregivers of younger children receiving multiple SCD modifying treatments (e.g., chronic transfusions or L-glutamine) will be excluded.\n\nRandomization: enrolled subjects will be eligible for randomization if they open their electronic adherence monitoring device at home at least once during the run-in period.\nHealthy volunteers allowed\nMust have minimum age of 11 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}